Literature DB >> 21744083

Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterification.

Caryl J Antalis1, Aki Uchida, Kimberly K Buhman, Rafat A Siddiqui.   

Abstract

We previously described a lipid-accumulating phenotype of estrogen receptor negative (ER(-)) breast cancer cells exemplified by the MDA-MB-231 and MDA-MB-436 cell lines. These cells had more lipid droplets, a higher uptake of oleic acid and LDL, a higher ratio of cholesteryl ester (CE) to triacylglycerol (TAG), and higher expression of acyl-CoA:cholesterol acyltransferase 1 (ACAT1) as compared to ER(+) MCF-7 breast cancer cells. LDL stimulated proliferation of ER-cells only, and proliferation was reduced by inhibition of ACAT. We hypothesized that storage of exogenous lipids would confer an energetic advantage. We tested this by depriving cells of exogenous lipids and measuring chemotactic migration, an energy-intensive behavior. MDA-MB-231 cells were grown for 48 h in medium with either 5% FBS or 5% lipoprotein-depleted (LD) FBS. Growth in LD medium resulted in visibly reduced lipid droplets and an 85% decrease in cell migration. Addition of LDL to the LD medium dose-dependently restored the ability to migrate in an ACAT-sensitive manner. LDL receptor (LDLR) mRNA was 12-fold higher in MDA-MB-231 cells compared to nontumorigenic ER-MCF-10A breast epithelial cells grown in LD medium. Addition of LDL to the LD medium reduced LDLR mRNA levels in MCF-10A cells only. We asked if ACAT1 activity was associated with the expression of the LDLR in MDA-MB-231 cells. LDLR mRNA in MDA-MB-231 cells was substantially reduced by inhibition of ACAT, demonstrating that high ACAT1 activity permitted higher LDLR expression. This data substantiates the association of lipid accumulation with aggressive behavior in an ER-breast cancer cell line.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21744083     DOI: 10.1007/s10585-011-9405-9

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  37 in total

Review 1.  Triple-negative breast cancer.

Authors:  William D Foulkes; Ian E Smith; Jorge S Reis-Filho
Journal:  N Engl J Med       Date:  2010-11-11       Impact factor: 91.245

2.  Expression of the low-density lipoprotein receptor, HMG-CoA reductase, and multidrug resistance (Mdr1) genes in colorectal carcinomas.

Authors:  S Vitols; P Gunvén; A Gruber; O Larsson
Journal:  Biochem Pharmacol       Date:  1996-07-12       Impact factor: 5.858

3.  Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiation.

Authors:  S Vitols; G Gahrton; A Ost; C Peterson
Journal:  Blood       Date:  1984-05       Impact factor: 22.113

4.  Cholesterol-induced growth stimulation, cell aggregation, and membrane properties of ascites tumor cells in culture.

Authors:  E W Haeffner; C J Hoffmann; M Stoehr; H Scherf
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

5.  Phosphorylation of alpha6-tubulin by protein kinase Calpha activates motility of human breast cells.

Authors:  Thushara P Abeyweera; Xiangyu Chen; Susan A Rotenberg
Journal:  J Biol Chem       Date:  2009-04-29       Impact factor: 5.157

6.  Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells.

Authors:  Maria T Accioly; Patricia Pacheco; Clarissa M Maya-Monteiro; Nina Carrossini; Bruno K Robbs; Silvia S Oliveira; Cristiane Kaufmann; José A Morgado-Diaz; Patricia T Bozza; João P B Viola
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

7.  X chromosomal abnormalities in basal-like human breast cancer.

Authors:  Andrea L Richardson; Zhigang C Wang; Arcangela De Nicolo; Xin Lu; Myles Brown; Alexander Miron; Xiaodong Liao; J Dirk Iglehart; David M Livingston; Shridar Ganesan
Journal:  Cancer Cell       Date:  2006-02       Impact factor: 31.743

Review 8.  A role for lipid droplets in inter-membrane lipid traffic.

Authors:  John K Zehmer; Youguo Huang; Gong Peng; Jing Pu; Richard G W Anderson; Pingsheng Liu
Journal:  Proteomics       Date:  2009-02       Impact factor: 3.984

9.  Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin.

Authors:  Serge Hardy; Wissal El-Assaad; Ewa Przybytkowski; Erik Joly; Marc Prentki; Yves Langelier
Journal:  J Biol Chem       Date:  2003-06-12       Impact factor: 5.157

10.  An intimate collaboration between peroxisomes and lipid bodies.

Authors:  Derk Binns; Tom Januszewski; Yue Chen; Justin Hill; Vladislav S Markin; Yingming Zhao; Christopher Gilpin; Kent D Chapman; Richard G W Anderson; Joel M Goodman
Journal:  J Cell Biol       Date:  2006-05-30       Impact factor: 10.539

View more
  67 in total

Review 1.  Metabolomic profiling of hormone-dependent cancers: a bird's eye view.

Authors:  Stacy M Lloyd; James Arnold; Arun Sreekumar
Journal:  Trends Endocrinol Metab       Date:  2015-08-01       Impact factor: 12.015

Review 2.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

Review 3.  Acidosis and cancer: from mechanism to neutralization.

Authors:  Arig Ibrahim-Hashim; Veronica Estrella
Journal:  Cancer Metastasis Rev       Date:  2019-06       Impact factor: 9.264

Review 4.  Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Biochim Biophys Acta       Date:  2015-05-09

5.  Drug-targeting in combined cancer chemotherapy: tumor growth inhibition in mice by association of paclitaxel and etoposide with a cholesterol-rich nanoemulsion.

Authors:  Iara F Kretzer; Durvanei A Maria; Raul C Maranhão
Journal:  Cell Oncol (Dordr)       Date:  2012-10-03       Impact factor: 6.730

6.  Circulating Lipoproteins: A Trojan Horse Guiding Squalenoylated Drugs to LDL-Accumulating Cancer Cells.

Authors:  Dunja Sobot; Simona Mura; Marie Rouquette; Branko Vukosavljevic; Fanny Cayre; Eric Buchy; Grégory Pieters; Sébastien Garcia-Argote; Maike Windbergs; Didier Desmaële; Patrick Couvreur
Journal:  Mol Ther       Date:  2017-06-09       Impact factor: 11.454

7.  Annexin A6 and Late Endosomal Cholesterol Modulate Integrin Recycling and Cell Migration.

Authors:  Ana García-Melero; Meritxell Reverter; Monira Hoque; Elsa Meneses-Salas; Meryem Koese; James R W Conway; Camilla H Johnsen; Anna Alvarez-Guaita; Frederic Morales-Paytuvi; Yasmin A Elmaghrabi; Albert Pol; Francesc Tebar; Rachael Z Murray; Paul Timpson; Carlos Enrich; Thomas Grewal; Carles Rentero
Journal:  J Biol Chem       Date:  2015-11-17       Impact factor: 5.157

8.  The cross-talk of LDL-cholesterol with cell motility: insights from the Niemann Pick Type C1 mutation and altered integrin trafficking.

Authors:  Monira Hoque; Carles Rentero; James R Conway; Rachael Z Murray; Paul Timpson; Carlos Enrich; Thomas Grewal
Journal:  Cell Adh Migr       Date:  2015-09-14       Impact factor: 3.405

Review 9.  Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism.

Authors:  Paolo E Porporato; Valéry L Payen; Bjorn Baselet; Pierre Sonveaux
Journal:  Cell Mol Life Sci       Date:  2015-12-08       Impact factor: 9.261

10.  Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing.

Authors:  Ryan T Davis; Kerrigan Blake; Dennis Ma; Mari B Ishak Gabra; Grace A Hernandez; Anh T Phung; Ying Yang; Dustin Maurer; Austin E Y T Lefebvre; Hamad Alshetaiwi; Zhengtao Xiao; Juan Liu; Jason W Locasale; Michelle A Digman; Eric Mjolsness; Mei Kong; Zena Werb; Devon A Lawson
Journal:  Nat Cell Biol       Date:  2020-03-06       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.